Found: 8
Select item for more details and to access through your institution.
Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2004, v. 130, n. 2, p. 59, doi. 10.1007/s00432-003-0502-2
- By:
- Publication type:
- Article
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 4, p. 548, doi. 10.1111/bjh.12382
- By:
- Publication type:
- Article
Estimated Savings After Stopping Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myeloid Leukemia.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 12, p. e2347950, doi. 10.1001/jamanetworkopen.2023.47950
- By:
- Publication type:
- Article
The Prognosis for Patients With Chronic Myeloid Leukemia Who Have Clonal Cytogenetic Abnormalities in Philadelphia Chromosome-Negative Cells.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 7, p. 1509, doi. 10.1002/cncr.22936
- By:
- Publication type:
- Article
Systemic mastocytosis in a patient with Cowden syndrome.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 12, p. 1154, doi. 10.1002/ajh.23815
- By:
- Publication type:
- Article
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0417-z
- By:
- Publication type:
- Article
Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article